These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32036210)

  • 1. Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling.
    Wu Y; Wang Y; Gong S; Tang J; Zhang J; Li F; Yu B; Zhang Y; Kou J
    Biomed Pharmacother; 2020 May; 125():109868. PubMed ID: 32036210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruscogenin attenuates particulate matter-induced acute lung injury in mice via protecting pulmonary endothelial barrier and inhibiting TLR4 signaling pathway.
    Wang YW; Wu YH; Zhang JZ; Tang JH; Fan RP; Li F; Yu BY; Kou JP; Zhang YY
    Acta Pharmacol Sin; 2021 May; 42(5):726-734. PubMed ID: 32855531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruscogenin attenuates sepsis-induced acute lung injury and pulmonary endothelial barrier dysfunction via TLR4/Src/p120-catenin/VE-cadherin signalling pathway.
    Wang Y; Xue L; Wu Y; Zhang J; Dai Y; Li F; Kou J; Zhang Y
    J Pharm Pharmacol; 2021 Jun; 73(7):893-900. PubMed ID: 33769524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
    Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
    Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
    Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C; Chen G; Yang W; Xu Y; Xu Y; Huang X; Liu J; Feng Y; Xu Y; Liu B
    Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells.
    Huang X; Zhu J; Jiang Y; Xu C; Lv Q; Yu D; Shi K; Ruan Z; Wang Y
    Drug Des Devel Ther; 2019; 13():1763-1772. PubMed ID: 31213766
    [No Abstract]   [Full Text] [Related]  

  • 8. Mogroside IIIE Attenuates LPS-Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF-κB Axis via AMPK Activation.
    Tao L; Cao F; Xu G; Xie H; Zhang M; Zhang C
    Phytother Res; 2017 Jul; 31(7):1097-1106. PubMed ID: 28512854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paeonol ameliorates lipopolysaccharides-induced acute lung injury by regulating TLR4/MyD88/ NF-κB signaling pathway.
    Wang F; Zhu M; Jiang N; Zhang M; Feng L; Jia X
    Pharmazie; 2019 Feb; 74(2):101-106. PubMed ID: 30782259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphA2 antagonism alleviates LPS-induced acute lung injury via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways.
    Feng G; Sun B; Liu HX; Liu QH; Zhao L; Wang TL
    Int Immunopharmacol; 2019 Jul; 72():176-185. PubMed ID: 30986645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway.
    Zhang Z; Chen N; Liu JB; Wu JB; Zhang J; Zhang Y; Jiang X
    Mol Med Rep; 2014 Jul; 10(1):101-6. PubMed ID: 24818579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttreatment With LYRM03 Protects Rats From Acute Lung Inflammation Induced by Lipopolysaccharide via Suppressing the NF-κB/MyD88/TLR4 Axis.
    Jiang Q; Wang S; Shi Y
    J Surg Res; 2019 Nov; 243():316-324. PubMed ID: 31255931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis.
    Chen SN; Tan Y; Xiao XC; Li Q; Wu Q; Peng YY; Ren J; Dong ML
    Acta Pharmacol Sin; 2021 Oct; 42(10):1610-1619. PubMed ID: 33495514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ugonin M, a Helminthostachys zeylanica Constituent, Prevents LPS-Induced Acute Lung Injury through TLR4-Mediated MAPK and NF-κB Signaling Pathways.
    Wu KC; Huang SS; Kuo YH; Ho YL; Yang CS; Chang YS; Huang GJ
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28368327
    [No Abstract]   [Full Text] [Related]  

  • 16. Apigenin C-glycosides of Microcos paniculata protects lipopolysaccharide induced apoptosis and inflammation in acute lung injury through TLR4 signaling pathway.
    Li K; He Z; Wang X; Pineda M; Chen R; Liu H; Ma K; Shen H; Wu C; Huang N; Pan T; Liu Y; Guo J
    Free Radic Biol Med; 2018 Aug; 124():163-175. PubMed ID: 29890216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The myosin II inhibitor, blebbistatin, ameliorates pulmonary endothelial barrier dysfunction in acute lung injury induced by LPS via NMMHC IIA/Wnt5a/β-catenin pathway.
    Zhang J; Pan Z; Zhou J; Zhang L; Tang J; Gong S; Li F; Yu B; Zhang Y; Kou J
    Toxicol Appl Pharmacol; 2022 Sep; 450():116132. PubMed ID: 35716767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: involvement of tissue factor, inducible NO synthase and nuclear factor (NF)-κB.
    Sun Q; Chen L; Gao M; Jiang W; Shao F; Li J; Wang J; Kou J; Yu B
    Int Immunopharmacol; 2012 Jan; 12(1):88-93. PubMed ID: 22079591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.